Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aczone and Tazorac in Moderate to Severe Facial Acne Vulgaris
NCT00834210Phase 4Completed
- Sponsor
- Allergan
- Start
- Dec 2008
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapsone in acne vulgaris, sponsored by Allergan. Started Dec 2008; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00834210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00834210.